| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 27 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2021 | Altshuler David48 | EVP, Global Research And CSO | Sell | 7,825 | $211.83 | $1,657,590.08 | -4.5% | +2.0% | +9.4% | |
| Feb 18, 2021 | Silva Paul M | SVP &Chief Accounting Officer | Sell | 4,295 | $211.83 | $909,827.62 | -7.2% | +2.0% | +9.4% | |
| Feb 18, 2021 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 9,264 | $211.83 | $1,962,366.00 | -4.4% | +2.0% | +9.4% | |
| Feb 11, 2021 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 4,460 | $210.55 | $939,067.80 | -2.3% | +1.0% | +11.1% | |
| Feb 11, 2021 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sell | 5,156 | $210.55 | $1,085,592.84 | -2.7% | +1.0% | +11.1% | |
| Feb 11, 2021 | Silva Paul M | SVP &Chief Accounting Officer | Sell | 1,498 | $210.57 | $315,436.80 | -3.0% | +1.0% | +11.1% | |
| Feb 11, 2021 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 1,686 | $210.56 | $355,012.33 | -2.1% | +1.0% | +11.1% | |
| Feb 11, 2021 | Parini Michael | EVP, Chief Adm, Leg &Bd Off | Sell | 4,318 | $210.56 | $909,178.74 | -2.8% | +1.0% | +11.1% | |
| Feb 11, 2021 | Altshuler David48 | EVP, Global Research And CSO | Sell | 5,283 | $210.54 | $1,112,273.86 | -4.7% | +1.0% | +11.1% | |
| Feb 5, 2021 | Parini Michael | EVP, Chief Adm, Leg &Bd Off | Sale+OE | 1,930 | $215.00 | $414,950.00 | -3.3% | -0.6% | +12.9% |